share_log

6-K: Jean-Paul Kress to join Sanofi's Board of Directors and Sanofi Initiates Phase 3 Program for PCV21 and Expands Collaboration with Sk Bioscience for Next-Generation Pneumococcal Conjugate Vaccines

6-K: Jean-Paul Kress to join Sanofi's Board of Directors and Sanofi Initiates Phase 3 Program for PCV21 and Expands Collaboration with Sk Bioscience for Next-Generation Pneumococcal Conjugate Vaccines

6-K:Jean-Paul Kress将加入赛诺菲安万特董事会以及赛诺菲安万特启动PCV21第三阶段研究计划,并扩大与SK bioscience的下一代肺炎球菌结合疫苗合作
美股SEC公告 ·  12/24 03:11
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息